Evonik launches MaxiPure Polysorbate 80 for injectable drug formulations
Ultra-high purity surfactant for biologics and parenteral drug formulations
Ultra-high purity surfactant for biologics and parenteral drug formulations
Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
Sessions will cover process mapping, cost optimisation, data-driven decision-making, cybersecurity, and sustainable manufacturing practices
Hengrui is eligible to receive regulatory and commercial milestone payments of up to US$1.093 billion
No post-injection Delirium/Sedation Syndrome (PDSS) observed through 56 weeks
Clinical evidence has consistently highlighted lacosamide’s efficacy and safety.
Subscribe To Our Newsletter & Stay Updated